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Objective: Mixed endometrial stromal and smooth muscle tumor (MESSMT)da rare mesenchymal
uterine tumor of the uterus with atypical clinical symptomsdis susceptible to misdiagnosis and missed
diagnosis. We report a case of a disseminated MESSMT with intravenous and intracardiac extensions
treated with staging surgery and review previously documented cases of such tumors with intracardiac
extension.
Case Report: The case involves a 45-year-old woman with disseminated MESSMT that originated in the
uterus and progressed through the iliac vein, inferior vena cava, right atrium, and into the right ventricle,
which closely resembled intravenous leiomyomatosis (IVL) grossly and microscopically. She presented
with a 1-year history of dyspnea on exertion. IVL was highly suspected preoperatively based on
computed tomography and magnetic resonance imaging ﬁndings. Two-stage surgeries were performed
successfully. The postoperative pathology indicated a disseminated MESSMT.
Conclusion: This case illustrates the important role of pathology and immunohistochemistry in the
differential diagnosis of a rare tumor that mimics the characteristics of IVL with intracardiac involvement
and demonstrates the therapeutic strategy for this rare entity.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Mixed endometrial stromal and smooth muscle tumor
(MESSMT) contains both endometrial stromal and smooth muscle
tissue with > 30% of each type of tissue. Initially reported as an
interstitial myoma [1], it is a rare mesenchymal uterine tumor with
atypical clinical symptoms. Owing to the atypical presentation, this
tumor is susceptible to misdiagnosis [especially with intravenous
leiomyomatosis (IVL)] and missed diagnosis. It has been seldom
reported in the literature, and there are only a few previouslygy, Third Xiangya Hospital,
ngsha City, Hunan Province
ics and Gynecology, Baylor
ouston, TX 77030, USA.
. Xu), xiaoming@bcm.edu
bstetrics & Gynecology. Publisheddocumented cases of such tumors with intracardiac extension
[2e4].
Complete resection of the intravascular and extravascular por-
tions of the tumor, although challenging, is mandatory in order to
relieve symptoms and prevent recurrence [4]. In cases with intra-
cardiac extension, the disease condition is particularly complicated,
given the venous and cardiac involvement. Surgery for such tumors
requires the participation of doctors from various disciplines and is
associated with high mortality and postoperative recurrence rates.
Single-stage and two-stage operations with cardiopulmonary
bypass (CPB) with or without hypothermic circulatory arrest have
been used for resection of tumors with caval and cardiac extensions
[4e6].
We report a case of a low-grade malignant and disseminated
MESSMT that originated in the uterus and progressed through the
iliac vein, inferior vena cava (IVC), right atrium, and into the right
ventricle that was successfully treated via two-stage operations
with CPB.by Elsevier Taiwan LLC. All rights reserved.
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A 45-year-old woman presented with a 1-year history of dys-
pnea on exertion that was alleviated with rest. Four years prior to
presentation, the patient underwent myomectomy in a local hos-
pital for a “benign leiomyoma” (no medical notes/pathological
specimens were available). One year following the myomectomy,
the patient was diagnosed with a recurrence of “uterine leio-
myoma” (later found to be MESSMT) during a medical checkup.
Regular ultrasound examinations revealed a gradually enlarging
“uterine leiomyoma.” The patient did not experience any changes in
menstruation patterns.
Clinical examination revealed a diastolic murmur at the left
sternal border and a slightly distended abdomen. Pelvic examina-
tion showed the cervix to be in a very high position; it could not be
exposed or palpated. Bimanual examination revealed a pelvic mass
consistent in size with a 24-week uterus and of irregular shape. The
mass was hard, ﬁxed, and nontender. The uterus could not be
palpated, and both adnexal regions were completely occupied by
the mass. Computed tomography and magnetic resonance imaging
(MRI) conﬁrmed a large mass (measuring 21.3
cm  10.8 cm  11.8 cm) in the abdominal cavity (Figures 1A and
1B). Intraluminal ﬁlling defects were observed within the right
common iliac vein, extending through the IVC, right atrium, and
into the right ventricle (Figure 1C). The pulmonary arteries were
free of any involvement.
With appropriate preoperative preparations, exploratory lapa-
rotomy was performed. The large, hard, and ﬁxed mass extended
deeply into the pelvis and upward to 5 cm above the umbilicus. The
uterus was difﬁcult to identify, although it was eventually located
to the left of the mass. The border between the mass and the
bladder was indistinct. The bladder walls were studded with
multiple 0.5e4-cm tumors that did not penetrate the mucous
membranes. The main body of the mass, uterus (Figure 2A), and
both fallopian tubes and ovaries were resected. Several dissemi-
nated masses were found deep in the pelvis: one on the left side of
the vagina, a second adjacent to the right ureter, and a third near
the right obturator foramen. The masses on the bladder walls,
retroperitoneum, and pelvic ﬂoor were removed (Figure 2B).
Because of the large size of the tumor and its invasiveness, exten-
sive hemorrhage occurred during the surgery. To avoid further
hemorrhage, pelvic lymph node dissection was not performed. The
postoperative pathological examination indicated a tumor withFigure 1. (A) Pelvic computed tomographic image showing a huge pelvic mass. (B) Magneti
the inferior vena cava and right atrium.endometrial stromal (Figure 3A) and smooth muscle origin
(Figure 3B) with low-grade malignancy, which fulﬁlled the deﬁni-
tion of MESSMT. The patient recovered uneventfully.
At 25 days after the ﬁrst-stage surgery, thoracoabdominal sur-
gery was performed under hypothermic CPB. Through abdominal
incisions, the abdominal vessels were completely exposed and
explored. The tumor's basal part was found in the right iliac vein. A
venotomywasmade at the junction of the iliac vein and IVC. Owing
to the delicate shape of the tumor in this junction, the tumor was
difﬁcult to separate from the iliac vein and was therefore dissected.
After incising the right iliac vein, the basal part of the tumor was
excised. Simultaneously, right atriotomy under extracorporeal
membranous oxygenation with beating heart was performed. A
solid tumormass was found in the right atrium contiguouswith the
tumor ﬁlling the IVC. A portion of the tumor in the right atrium
branched into the right ventricle through the tricuspid valve,
making a “Y” shape. Although the tumor was space ﬁlling, it did not
adhere to the venous or cardiac walls. The branching part of the
tumor was extracted from the right ventricle through the tricuspid
valve; then, the entire tumor was completely pulled out through
the IVC. The ﬁnal specimen measured ~33 cm and was grayish
white, cylindrically shaped, smooth, and hard (Figure 2C). The
histopathological examination indicated a cellular morphology
identical to that of the tumor removed in the ﬁrst-stage operation.
The patient recoveredwell from the surgery and was discharged
home 12 days postoperatively. We recommended toremifene cit-
rate tablets to prevent tumor recurrence postoperatively. Three
months after the surgery, the patient was doing well with no signs
of recurrence.
For this report, we obtained the informed consent of the patient
and approval from the Independent Ethics Committee of Central
South University, Changsha City, China.
Discussion
MESSMTcontains both endometrial stromal and smoothmuscle
tissues, and must contain > 30% of each type of tissue to meet the
deﬁnition of MESSMT. MESSMT has biological behavior similar to
IVL in that it can display vascular invasiondsuch as in this case, in
which the tumor invaded the iliac veins, IVC, right atrium, and right
ventricle. MESSMT is easily misdiagnosed as IVL or endometrial
stromal tumor (EST). The differential diagnosis is difﬁcult because
of the similar clinical presentations; therefore, pathological andc resonance image (MRI) showing the uterus and mass. (C) MRI showing the masses in
Figure 2. (A) The resected main body of the tumor and uterus. (B) The tumors from the bladder walls, retroperitoneum, and bottom of the pelvis. (C) The tumors in the vein and the
heart.
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IVL is an uncommon benign smooth muscle uterine tumor that
grows along the veins. Its biological behaviors are similar to those
of malignant tumors with high rates of recurrence and metastasis.
It migrates to the endometrial smooth muscle lining the veins,
which enables extrauterine extension. So far, the pathogenesis is
thought to be one of two possible origins: one theory is that this
type of tumor develops from a preexisting benign uterine leio-
myoma; the other is that it originates from smooth muscle cells
within the walls of a uterine vein [7]. EST is a rare kind of malignant
uterine tumor originating frommesenchymal stem cells, which can
potentially differentiate into mature endometrial stroma or into
endometrial smooth muscle [8]. EST is considered to be an
estrogen-dependent sarcoma [9]. This tumor can invade the
lymphatic system or vessels, although it rarely involves the large
vessels or the heart [3]. ESTs are more aggressive than IVL and have
greater propensity for local invasion and systemic metastasis. Low-
grade malignant endometrial stromal sarcomas are considered to
be biologically similar to pure smooth muscle tumors [2,3].
A literature review revealed three cases of this type of MESSMT
with intracardiac extension. These cases differed from the presentFigure 3. The ﬁnal diagnosis is mixed endometrial stromal and smooth muscle tumor. Hist
(A) CD10 (endometrial stromal cells) and (B) desmin (smooth muscle differentiation).case: they were diagnosed at a later stage, with the tumors dis-
playing a more aggressive behavior with pelvic, caval, and intra-
cardiac recurrences [2,3]. In the third case, the tumor had extended
to the pulmonary vessels, and it had a higher rate of sudden death
[4]. Previously documented cases of such tumors with intracardiac
extension are reviewed in Table 1.
Complete surgical tumor resection is the best treatment for this
tumor. The surgical approach should be guided by preoperative
determination of the site of origin of the tumor and the degree of
extension into the veins, heart, and pulmonary arteries. In these
patients, venous cannulation for CPB may be challenging. Coganow
et al [4] successfully performed single-stage resection of this tumor
with CPB. Staged surgical approaches have also been used for tumor
resection involving cardiac extension [6]. We chose a staged sur-
gical approach for the following reasons. (1) Preoperatively, the
pathological diagnosis and true extent of the tumor was unclear.
The large size of the pelvic mass with its extensive abdominal in-
vasion and inﬁltration was expected to render the removal of the
intravascular tumor extremely difﬁcult in a one-stage procedure.
(2) Single-stage surgery requires longer procedural duration, re-
sults in a large surgical pedicle, and carries a greater risk of massive
hemorrhage from the surgical ﬁeld because of heparinizationological examination of the resected specimen with immunohistochemical staining for
Table 1
Clinical summary of documented cases of MESSMT with intracardiac extension.
Ref. Year Age (y) Original diagnosis Final diagnosis Metastasis Surgery Follow-up
[2] 1987 50 IVL MESSMT IVC, right atrium Staging surgery Patient died after 8 y
[3] 1999 24 IVL MESSMT IVC, right atrium right lung Staging surgery Asymptomatic at 12 y
[4] 2006 47 No record MESSMT IVC, right atrial pulmonary Multiple-stage operation No recurrence at 9 mo
Our case 2014 45 IVL MESSMT IVC, right atrial right ventricle Staging surgery No recurrence at 3 mo
IVL ¼ intravenous leiomyomatosis; IVC ¼ inferior vena cava; MESSMT ¼ mixed endometrial stromal and smooth muscle tumor.
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In the ﬁrst stage, the pelvic and abdominal tumors were removed.
In the second stage, the right cardiac and venous tumors were
removed under CPB.
Because MESSMT is an estrogen-dependent tumor, post-
operative antiestrogen medication, such as toremifene citrate tab-
lets or tamoxifen, may have therapeutic effects on preventing
tumor relapse, particularly for patients with incompletely removed
tumors [3].
Preoperative diagnosis with computed tomography and MRI is
important for pelvic tumors with intravenous extension, particu-
larly when complicated by venous and/or cardiac involvement. MRI
can provide clarity regarding the relationship of the tumor with the
vessel wall, i.e., whether the tumor is densely adhesive to the vessel
wall. Such information is critical to the successful removal of the
tumor because sloughing of the tumor thrombus can cause pul-
monary artery embolism and sudden death. Owing to the similar
biological behaviors of MESSMTand IVL, postoperative pathological
and immunohistochemical examinations are vital to distinguish
the two diseases. In patients with MESSMT, long-term surveillance
is necessary because of the high mortality and postoperative
recurrence rates associated with this tumor.Conﬂicts of interest
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